نتائج البحث - Sonia Morè
- يعرض 1 - 5 نتائج من 5
-
1
-
2
Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments حسب Massimo Offidani, Laura Corvatta, Sonia Morè, Davide Nappi, Giovanni Martinelli, Attilio Olivieri, Claudio Cerchione
منشور في 2021Revisão -
3
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma حسب Luca Bertamini, Stefania Oliva, Delia Rota‐Scalabrini, Laura París, Sonia Morè, Paolo Corradini, A Ledda, Massimo Gentile, Giovanni De Sabbata, Giuseppe Pietrantuono, Anna Pascarella, Patrizia Tosi, Paola Curci, Milena Gilestro, Andréa Capra, Piero Galieni, Francesco Pisani, Ombretta Annibali, Federico Monaco, Anna Marina Liberati, Salvatore Palmieri, Mario Luppi, Renato Zambello, Francesca Fazio, Angelo Belotti, Paola Tacchetti, Pellegrino Musto, Mario Boccadoro, Francesca Gay
منشور في 2022Artigo -
4
Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab‐Refractory Multiple Myeloma Patients: A Multicenter Real‐World Study حسب Enrica Antonia Martino, Daniele Derudas, Elena Rossi, Paola Stefanoni, Silvia Mangiacavalli, Elena Zamagni, Massimo Offidani, Anna Furlan, Angela Maria Quinto, Roberta Della Pepa, Giuseppe Bertuglia, Emiliano Barbieri, Concetta Conticello, Claudio De Magistris, Velia Bongarzoni, Anna Maria Cafro, Anna Mele, Cirino Botta, Nicola Sgherza, Giuseppe Mele, Ombretta Annibali, Angela Rago, Raffaele Fontana, Ernesto Vigna, Antonella Bruzzese, Katia Mancuso, Angela Amendola, Annalisa Citro, Emilia Cotzia, Sonia Morè, Elena Rivolti, Loredana Pettine, Mónica Galli, Valerio De Stefano, Maria Teresa Petrucci, Alessandro Corso, Antonino Neri, Francesco Di Raimondo, Niccolò Bolli, Pellegrino Musto, Fortunato Morabito, Massimo Gentile
منشور في 2025Artigo -
5
Comparison of isatuximab-pomalidomide-dexamethasone <i>versus</i> elotuzumab-pomalidomidedexamethasone in relapsed/refractory multiple myeloma patients: a target trial... حسب Enrica Antonia Martino, Annalisa Pitino, Massimo Offidani, Roberta Della Pepa, Alessandro Gozzetti, Velia Bongarzoni, Antonio Maroccia, Valeria Amico, Paola Stefanoni, Elena Zamagni, Sofia Terlizzi, Daniele Derudas, Salvatore Palmieri, Rosario Bianco, Concetta Conticello, Marino Brunori, Angela Rago, Flavia Lotti, Raffaele Fontana, Nicola Sgherza, Elena Rossi, Anna Maria Cafro, Massimiliano Arangio Febbo, Angela Maria Quinto, Claudio Cerchione, Gloria Margiotta Casaluci, Annalisa Citro, Catello Califano, Renato Zambello, Silvia Mangiacavalli, Carmine Liberatore, Gabriele Buda, Claudio De Magistris, Angela Amendola, Ernesto Vigna, Antonella Bruzzese, Emiliano Barbieri, Micol Quaresima, Daniela Roccotelli, Francesca Farina, Jacopo Micozzi, Iolanda Donatella Vincelli, Giuseppe Tarantini, Elisabetta Antonioli, Sara Aquino, Alessandro Maggi, Alessandra Lombardo, Giuseppe Bertuglia, Anna Furlan, Anna Mele, Ombretta Annibali, Emilia Cotzia, Pietro Benvenuti, Lorenzo De Paoli, Gregorio Barilà, Sonia Morè, Valerio De Stefano, Francesco Di Raimondo, Maria Teresa Petrucci, Niccolò Bolli, Pellegrino Musto, Antonino Neri, Fortunato Morabito, Giovanni Tripepi, Massimo Gentile
منشور في 2025Artigo
أدوات البحث:
موضوعات ذات صلة
Internal medicine
Medicine
Multiple myeloma
Oncology
Astrobiology
Refractory (planetary science)
Biology
Lenalidomide
Daratumumab
Dexamethasone
Gastroenterology
Physics
Pomalidomide
Adverse effect
Antibody
Bone marrow
Clinical trial
Confidence interval
Context (archaeology)
Drug
Emulation
Hazard ratio
Immunology
Intensive care medicine
Interquartile range
Medical physics
Minimal residual disease
Monoclonal antibody
Multivariate analysis
Overall survival